D25A/0491/WEB: Amendments and alterations to the previously approved 3-storey Pharmaceutical Building extension (referred to as ADL2) and ancillary development as previously approved under Reg. Ref. D19A/0904. As part of the granted permission (Reg. Ref. D19A/0904) the 3-storey Pharmaceutical Building extension, subject to this application, comprised a floor area of approximately 17,000 sq.m and a height of approximately 19 metres. The proposed amendments and alterations to the building include: (i) An increase in the overall footprint and gross floor area of the building from c. 17,000sq.m to c. 17,685sq.m. The overall building height will remain at c.19 metres; (ii) A reduction in the level of the ground floor level slab; (iii) The manufacturing activity to be undertaken within the amended building will be limited to product fill & finish. Biological-based pharmaceutical manufacturing processes within the building are no longer proposed; (iv) Omission of the previously approved ground floor level link corridor, previously providing a connection to the neighbouring building to the immediate south; (v) Reconfiguration of the internal layouts from ground to second floor levels and the provision of a corridor linking the amended building to the Coldchain Warehouse building to the north-east; (vi) alterations to the roof plan to include the re-positioning of roof vents, the addition of ventilation ducts, roof mounted chillers, and the provision of railings around the building parapets. Access to the roof level is provided via 2 no. stair cores from second floor level; (vii) Alterations to the external facades, including the re-arrangement of glazing, louvres and panels and amendments to personnel and roller shutter doors; (viii) Realignment and re-grading of roads and footpaths surrounding the building, including the rearrangement of the turning area for emergency vehicles; (ix) realignment of underground drainage and services in the vicinity of the building, together with an increase in the size of the stormwater attenuation system serving the development; (x) enhancements to landscaping around the building; and (xi) all associated site and development works necessary to facilitate the development. This application relates to amendments to a previously approved development which comprises an activity which holds an Industrial Emissions Licence (Reg. No. P0019-02) in accordance with the First Schedule of the EPA Act 1992 as amended.

Planning a project near Amgen Technology (Ireland), Pottery Road, Dun Laoghaire, Dublin, A96F2A8?